LUMRYZ: payments to doctors
Payments that named LUMRYZ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.4M
- Providers
- 5,272
- Transactions
- 22,870
- Average per transaction
- $150
The per-transaction average — $150 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,272 providers the average total is $653, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | $3,439,998 | 100.0% |